We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

217 hedge funds and large institutions have $1.1B invested in SANGAMO THERAPEUTICS INC in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 57 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 57

25% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 28

19% more capital invested

Capital invested by funds: $919M → $1.1B (+$178M)

3% more funds holding

Funds holding: 210 → 217 (+7)

0% more call options, than puts

Call options by funds: $36.1M | Put options by funds: $36M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.09% less ownership

Funds ownership: 63.79% → 63.7% (-0.09%)

Holders
217
Holders Change
+7
Holders Change %
+3.33%
% of All Funds
4.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
35
Increased
74
Reduced
57
Closed
28
Calls
$36.1M
Puts
$36M
Net Calls
+$97K
Net Calls Change
+$2.61M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$15.5M
2
Goldman Sachs
Goldman Sachs
New York
+$9.13M
3
CC
Casdin Capital
New York
+$9.12M
4
WA
Wasatch Advisors
Utah
+$7.39M
5
Millennium Management
Millennium Management
New York
+$6.81M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$28.1M
2
EC
EcoR1 Capital
California
-$17.7M
3
NC
Nexthera Capital
New York
-$15.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$10.4M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
WSTAM
201
Wilbanks Smith & Thomas Asset Management
Virginia
$5K +$4.56K +300 New
TDC
202
Thompson Davis & Co
Virginia
$4K – – –
MAM
203
Meeder Asset Management
Ohio
$3K -$7.74K -509 -77%
PS
204
Portfolio Strategies
New York
$3K – – –
SEI Investments
205
SEI Investments
Pennsylvania
$3K +$1.08K +71 +59%
GEA
206
Glen Eagle Advisors
New Jersey
$2.12K +$1.9K +125 New
Northwestern Mutual Wealth Management
207
Northwestern Mutual Wealth Management
Wisconsin
$2K -$35.7K -2,348 -94%
IP
208
Isthmus Partners
Wisconsin
$2K – – –
AOWM
209
Alpha Omega Wealth Management
Virginia
$2K +$912 +60 +100%
CAC
210
Certified Advisory Corp
Florida
$2K +$912 +60 +100%
SWM
211
SeaCrest Wealth Management
New York
$2K +$1.52K +100 New
JFA
212
JNBA Financial Advisors
Minnesota
$2K +$1.82K +120 New
VFA
213
Valeo Financial Advisors
Indiana
$2K +$2.1K +138 New
RCAG
214
Rehmann Capital Advisory Group
Michigan
$1.24K – – –
QCG
215
Quadrant Capital Group
Ohio
$1K – – –
NFG
216
Next Financial Group
Texas
$1K +$897 +59 New
WOC
217
West Oak Capital
California
$848 – – –
NC
218
Nexthera Capital
New York
– -$15.2M -1,066,914 Closed
Parallax Volatility Advisers
219
Parallax Volatility Advisers
California
– -$2.48M -162,868 Closed
TCP
220
Tourbillon Capital Partners
New York
– -$2.23M -157,231 Closed
BCPEM
221
Bain Capital Public Equity Management
Massachusetts
– -$2M -140,992 Closed
WC
222
Wexford Capital
Florida
– -$1.81M -127,800 Closed
SLG
223
Stanley-Laman Group
Pennsylvania
– -$1.53M -107,548 Closed
CM
224
Caption Management
Oklahoma
– -$876K -61,667 Closed
WAP
225
Wealthcare Advisory Partners
Pennsylvania
– -$710K -50,000 Closed
6 7 8
9
10

SGMO Hedge Fund Activity: Q3 2018 in Review

217 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2018, worth a combined $1.1B — up 19% from $919M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new SGMO positions and 28 closed out — a net gain of 7 holders — while 74 added to existing stakes and 57 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $15.5M. The largest seller was Adage Capital Partners, cutting an estimated $28.1M.

  • 217 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2018, up from 210 in Q2 2018.
  • Funds reported $1.1B of SANGAMO THERAPEUTICS INC stock for Q3 2018, up 19% quarter-over-quarter.
  • 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2018 and 28 closed out, a net change of +7 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2018 was Wellington Management Group, an estimated $15.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2018 was Adage Capital Partners, an estimated $28.1M sold.

Based on aggregated 13F filings for Q3 2018.